American Academy of Pain Medicine response to PROP petition to the FDA that seeks to limit pain medications for legitimate noncancer pain sufferers
Pain Med
.
2012 Oct;13(10):1259-64.
doi: 10.1111/j.1526-4637.2012.01493.x.
Epub 2012 Sep 21.
Authors
Perry Fine
,
Lynn Webster
,
Charles Argoff
PMID:
22998637
DOI:
10.1111/j.1526-4637.2012.01493.x
No abstract available
Publication types
Editorial
MeSH terms
Academies and Institutes
Analgesics, Opioid / therapeutic use*
Drug Prescriptions*
Humans
Pain / drug therapy*
Pain Management*
United States
United States Food and Drug Administration
Substances
Analgesics, Opioid